|
Edited by
Pat Price, MA, MD, FRCR, FRCP, visiting professor of oncology, Imperial College London, UK.
Karol Sikora, MA, MBBChir, PhD, MD, FRCR, FRCP, FRCPE, FFPM, chief medical officer, Cancer Partners UK, and dean, University of Buckingham Medical School, UK. |